Gianluca Gaidano, MD, PhD, is Professor of Hematology at the Medical School of the University of Eastern Piedmont, Novara, Italy. He is also the Director of the Division of Hematology of the Academic Hospital “Maggiore della Carità di Novara”. He is a member of EHA, ASH, ASCO, AACR, Henry Kunkel Society, SIE and SIES, and a former President of the Italian Society of Experimental Hematology. He has been a board member of EHA, and is currently Chair of the EHA Global Outreach Program. He has served in the EHA Scientific Program Committee and Fellowship and Grant Committee, and is currently serving in the EHA Education Committee. He is a board member of the Italian Lymphoma Foundation (FIL), of the Italian Society of Hematology, and of the GIMEMA Working Party on chronic lymphoproliferative disorders. He started his medical career at the University of Turin, where he received his M.D. (1987) and Ph.D (1991), and became a specialist in Internal Medicine and Hematology. From 1990 to 1994, he was at Columbia University (Dalla-Favera’s lab), New York, where he trained in molecular hematology. His research interests relate mainly to the clinical implications of the molecular genetics of lymphoid malignancies, with a particular focus on new diagnostic and prognostic markers and targeted treatments for B-cell malignancies. Other fields of interest concern hematologic neoplasias developing in immunodeficient patients. He has contributed to several hematology and oncology textbooks, and has published over 600 scientific articles.